Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets
08:07 EDT 28 Jun 2012 | PharmPro
Mylan Inc. today confirmed that the company has been sued by Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration..
Original Article: Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets
More From BioPortfolio on "Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
